351 related articles for article (PubMed ID: 25791893)
21. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
Lee YJ; Kang HC; Kim HD; Lee JS
Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
[TBL] [Abstract][Full Text] [Related]
23. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and safety of adjunctive levetiracetam in children younger than 4 years with refractory epilepsy].
Hu Y; Liao JX; Chen L; Huang TS; Li B
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):256-8. PubMed ID: 20416214
[TBL] [Abstract][Full Text] [Related]
25. Effect of levetiracetam in refractory childhood epilepsy syndromes.
Lagae L; Buyse G; Deconinck A; Ceulemans B
Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of levetiracetam for focal seizures and its blood levels in children.
Iwasaki T; Toki T; Nonoda Y; Ishii M
Brain Dev; 2015 Sep; 37(8):773-9. PubMed ID: 25579248
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
29. [The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
Aĭvazian SO; Shiriaev IuS
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):33-8. PubMed ID: 22500310
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
31. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
[TBL] [Abstract][Full Text] [Related]
32. Lamotrigine serum concentration in children with epilepsy.
Heyman E; Lavie R; Lahat E; Braunstein R; Bar-Haim A; Berkovitch M; Gandelman-Marton R
Pediatr Neurol; 2012 Dec; 47(6):427-30. PubMed ID: 23127263
[TBL] [Abstract][Full Text] [Related]
33. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
Steinhoff BJ; Trinka E; Wieser HG;
Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam monotherapy for the treatment of infants with epilepsy.
Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy.
Kanemura H; Sano F; Tando T; Sugita K; Aihara M
Brain Dev; 2013 May; 35(5):386-91. PubMed ID: 22871391
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam as add-on therapy in generalised epilepsies.
Kumar SP; Smith PE
Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
[TBL] [Abstract][Full Text] [Related]
39. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel C; Holthausen H; Kluger G
Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
[TBL] [Abstract][Full Text] [Related]
40. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
